Cargando…

Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study

Blood-based biomarkers can be economic and easily accessible tools for monitoring and predicting disease activity in multiple sclerosis. The objective of this study was to determine the predictive value of a multivariate proteomic assay for concurrent and future microstructural/axonal brain patholog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakimovski, Dejan, Qureshi, Ferhan, Ramanathan, Murali, Gehman, Victor, Keshavan, Anisha, Leyden, Kelly, Dwyer, Michael G, Bergsland, Niels, Weinstock-Guttman, Bianca, Zivadinov, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288551/ https://www.ncbi.nlm.nih.gov/pubmed/37361716 http://dx.doi.org/10.1093/braincomms/fcad183

Ejemplares similares

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Retinal Blood Vessel Analysis Using Optical Coherence Tomography (OCT) in Multiple Sclerosis
por: Young, Nicholas, et al.
Publicado: (2023)

Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2023)

The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging
por: Guan, Yi, et al.
Publicado: (2019)

Relationships Among Circulating Levels of Hemostasis Inhibitors, Chemokines, Adhesion Molecules, and MRI Characteristics in Multiple Sclerosis
por: Ziliotto, Nicole, et al.
Publicado: (2020)

Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI
por: Fuchs, Tom A., et al.
Publicado: (2021)

Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals
por: Hagemeier, Jesper, et al.
Publicado: (2017)

Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study
por: Jakimovski, Dejan, et al.
Publicado: (2019)

Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study
por: Schwartz, Carolyn E., et al.
Publicado: (2016)

Cortical and Deep Gray Matter Perfusion Associations With Physical and Cognitive Performance in Multiple Sclerosis Patients
por: Jakimovski, Dejan, et al.
Publicado: (2020)

MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsy
por: Goldberg, Hila, et al.
Publicado: (2014)

Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal study
por: Tavazzi, Eleonora, et al.
Publicado: (2020)

Measuring Aqueduct of Sylvius Cerebrospinal Fluid Flow in Multiple Sclerosis Using Different Software
por: Laganà, Maria Marcella, et al.
Publicado: (2021)

Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI
por: Schweser, Ferdinand, et al.
Publicado: (2020)

DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis
por: Dwyer, Michael, et al.
Publicado: (2021)

Reserve-building activities in multiple sclerosis patients and healthy controls: a descriptive study
por: Schwartz, Carolyn E., et al.
Publicado: (2015)

Centralized and Local Color Doppler Ultrasound Reading Agreement for Diagnosis of the Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis
por: Caprio, Maria Grazia, et al.
Publicado: (2017)

Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis
por: Fuchs, Tom A., et al.
Publicado: (2019)

Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2012)

Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
por: Weinstock-Guttman, Bianca, et al.
Publicado: (2011)

Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis
por: Malyavantham, Kishore, et al.
Publicado: (2015)

Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain
por: Hagemeier, Jesper, et al.
Publicado: (2017)

Use of patient-reported data in determining factors contributing to internal jugular vein stenosis outcomes
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Editorial of Special Issue “Multiple Sclerosis: From Diagnostic Biomarkers to Imaging and Clinical Predictors”
por: Jakimovski, Dejan, et al.
Publicado: (2022)

Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study
por: Barnett, Michael, et al.
Publicado: (2021)

Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2019)

No association between variations in extracranial venous anatomy and clinical outcomes in multiple sclerosis patients over 5 years
por: Gandhi, Sirin, et al.
Publicado: (2019)

Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2014)

Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS
por: Zivadinov, Robert, et al.
Publicado: (2016)

An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice—The MS‐MRIUS Study
por: Zivadinov, Robert, et al.
Publicado: (2016)

Cognitive Profiles of Aging in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2019)

Iron deposition and inflammation in multiple sclerosis. Which one comes first?
por: Zivadinov, Robert, et al.
Publicado: (2011)

Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
por: Tao, Yazhong, et al.
Publicado: (2015)

Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives
por: Ozel, Osman, et al.
Publicado: (2019)

Tixagevimab and Cilgavimab (Evusheld™) Prophylaxis Prevents Breakthrough COVID-19 Infections in Immunosuppressed Population: 6-Month Prospective Study
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fdtg1qev45uli5r74i0h2fhgvc